期刊文献+

钠通道激活剂维司力农的药理与临床研究进展 被引量:3

PROGRESS IN PHARMACOLOGICAL AND CLINICAL RESEARCH OF VESNARINONE——SODIUM CHANNEL ACTIVATOR
下载PDF
导出
摘要 维司力农可增强心肌收缩力,延长动作电位时程(APD),对心率及心肌耗氧量影响很小,低剂量用于慢性充血性心衰病人。其作用主要是抑制钠通道失活,延长开放状态,Na+内流增多,Na+-Ca2+交换加强,使细胞内〔Ca2+〕升高。另外,维司力农尚有松弛支气管平滑肌,抑制细胞因子的生成而具有免疫抑制作用,对癌细胞的诱导分化作用以及抑制骨髓造血系统引起白血细胞减少。 The pharmacological action and clinical application of vesnarinone,a sodium channel activator,were reviewed.Vesnarinone increases myocardial contractile(a positive inotropic effect)and action potential duration(APD).Its mechanism is related to inhibition of sodium channel,inactivating and increase of intracellular calicium concentration.Vesnarinone is very active on chronic congestive heart failure.Furthermore vesnarinone relaxes airway smooth muscle,inhibits cytokine production,induces cellular differentiation and apoptosis,and suppresses bone marrow progenitor cells and peripheral lymphocytes.
机构地区 中国医学科学院
出处 《中国新药杂志》 CAS CSCD 1997年第1期24-29,共6页 Chinese Journal of New Drugs
关键词 维司力农 钠通道激活剂 正性肌力效应 心力衰竭 Vesnarinone Sodium channel activator Positive intropic action Chronic congestive heart failure
  • 相关文献

同被引文献36

  • 1[2]Sasayama S, Matsumori A, Matoba Y. Immunomodulation:a new horizon for medical treatment of hearfailure. J Card Fail,1996; 2 (4 Suppl): S287
  • 2[3]Sasayama S, Matsumori A. Vesnarinone: a potential cytokine inhibitor. J Card Fail, 1996;2(3):251
  • 3[4]Matsumori A, Sasayama S. Immunomodulating agents for the management of heart failure with myocarditis and cardiomy opathy lessons from animal experiments. Eur Heart J, 1995;16SupplO: 140
  • 4[5]Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol, 1996; 11 (3): 302
  • 5[6]Sato Y, Matsumori A, Sasayama S, et al. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbiliced vein endothilial cells. J Mol Cell Cardiol, 1995; 27(1 ): 2265
  • 6[7]Oyaizu N, McCloskey TW, Than S. Inhibition of CD4Cross-linking-induced lymphocytes apoptosis by resnarinone as a novel immunomodulating gent: vesnarinone inhibitis Fas expression and apoptosis by blocking cytokine secretion. Blood, 1996;87(6) :2361
  • 7Kikuchi T, Tottori K, Uwahodo Y, et al. OPC-14597, a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity[J]. J Pharmacol Exp Ther , 1995,274( 1 ): 329-336.
  • 8Oshiro Y, Sato S, Kurahashi N, et al. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7- [ 4- ( 4- phenyl- 1- piperazinyl) butoxy ] 3, 4-dihydro-2 ( 1H)-quinolinone derivatives [ J ]. J Med Chem, 1998,41(5) :658-667.
  • 9ZhaoH, ThurkaufA, Braun J, etal. Design, synthesis, and discovery of 3-piperazinyl- 3,4-dihydro-2 ( 1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists[J]. Bioorg Med Chem Lett , 2000,10(18):2119-2122.
  • 10Oshiro Y, Sakurai Y, Sato S, et al. 3,4-dihydro-2(1H)quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[ 3-[ 4-( 3-chlorophenyl )-1-piperazinyl ]propyl]-3, 4-dihydro-5-methoxy-2 ( 1H )-quinolinone and its derivatives[J]. J Med Chem, 2000, 43(2): 177-189.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部